Pathway for the Management of Atrial Fibrillation and Atrial Flutter

Critical Pathways in Cardiology
Eyal HerzogEmad Aziz

Abstract

Atrial fibrillation (AF) is the most common cardiac rhythm disturbance encountered in clinical practice, and its prevalence is increasing as the population ages. The American College of Cardiology, the American Heart Association, and the European Society of Cardiology established guidelines for the management of patients with AF. Atrial flutter (Afl) is less common and is often associated with or preceded by AF or occurs in an isolated pattern. A major limitation of the currently published guidelines for the management of patients with AF and Afl is their complexity, the fact that official guidelines are published separately for each of these arrhythmias, and that they were published several years ago. To address these deficiencies, we have developed a novel pathway for the management of AF and Afl. The pathway has been designated with the acronym RACE, which reflects the 4 main components in patient management: rate control, anticoagulation therapy, cardioversion, and electrophysiology/antiarrhythmic medication. This pathway is an attempt to incorporate, in a user-friendly format, the key concepts of the initial diagnosis and management of these prevalent arrhythmias. This is followed by a comprehensive guideline for therapy u...Continue Reading

References

May 11, 2001·The New England Journal of Medicine·A L KleinUNKNOWN Assessment of Cardioversion Using Transesophageal Echocardiography Investigators
Oct 30, 2003·The American Journal of Cardiology·Anvar BabaevJonathan S Steinberg
Sep 1, 2004·International Journal of Cardiology·Ijaz A KhanReshma C Nair
Mar 22, 2005·Current Problems in Cardiology·A Hersi, D G Wyse
Sep 18, 2007·Seminars in Thoracic and Cardiovascular Surgery·Edward P Ingenito, Larry W Tsai
Dec 12, 2007·Pacing and Clinical Electrophysiology : PACE·Delia CotigaJonathan S Steinberg
Mar 15, 2008·Critical Pathways in Cardiology·Eyal HerzogAlan Rozanski
Mar 15, 2008·Critical Pathways in Cardiology·Eyal HerzogMarrick Kukin
Mar 30, 2013·Journal of the American Heart Association·Anand N GanesanPrashanthan Sanders
Jun 26, 2014·The New England Journal of Medicine·Tommaso SannaUNKNOWN CRYSTAL AF Investigators

❮ Previous
Next ❯

Citations

Feb 28, 2018·Journal of Cardiovascular Pharmacology and Therapeutics·Sanghun Lee, Nam Kyung Je
Mar 28, 2020·Pulmonary Circulation·Cyrus A VahdatpourHarold I Palevsky

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.